Aterian declares CVR dividend; investor to buy 3.5M convertible preferred
AI Summary
Aterian, Inc. filed SEC Form 8-K. Aterian's board declared a contingent value right (CVR) dividend to holders of common stock and participating warrants of record as of July 8, 2026, with payment to be made within 60 days after the record date and no later than September 4, 2026, contingent on closing of the asset sale and securities purchase. Separately, David E. Lazar agreed to purchase 1,750,000 shares of Series AA and 1,750,000 shares of Series AAA convertible preferred (3.5M total) from the company — these are preferred shares (company-issued) that could create future common share dilution if converted, but conversion terms and timing were not disclosed. The filing estimates net proceeds available to distribute via the CVR from the transactions of roughly $10.6M–$14.2M (approximately $0.85–$1.14 per common share), though amounts are subject to adjustments, reserves and closing conditions.
Positives
- Company intends to distribute remaining cash proceeds to stockholders via CVR
- Estimated available distribution range: $10.6M–$14.2M (≈ $0.85–$1.14/share)
- CVR payment window set within 60 days after record date and no later than Sept 4, 2026
Negatives
- Company is issuing 3.5M convertible preferred to one investor (David E. Lazar) — potential future common dilution on conversion
- CVR amounts and timing are contingent on asset-sale closing, SPA adjustments, and reserves, so distribution is uncertain
- Record date (July 8, 2026) allows unexercised participating warrants to convert into additional CVR-entitled shares if exercised before that date, potentially increasing payable CVRs
Filing Context
Filing and Dilution Context
Earliest dilution
Earliest dilution: date unknown
Dilution status
potential
Dilution timing
Dilution status: Undetermined
Trigger type
conversion